These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
181 related articles for article (PubMed ID: 6847695)
1. Structure-activity relationship of ligands of the pyrimidine nucleoside phosphorylases. Niedzwicki JG; el Kouni MH; Chu SH; Cha S Biochem Pharmacol; 1983 Feb; 32(3):399-415. PubMed ID: 6847695 [TBL] [Abstract][Full Text] [Related]
2. New analogues of benzylacyclouridines, specific and potent inhibitors of uridine phosphorylase from human and mouse livers. Naguib FN; el Kouni MH; Chu SH; Cha S Biochem Pharmacol; 1987 Jul; 36(13):2195-201. PubMed ID: 3606636 [TBL] [Abstract][Full Text] [Related]
3. Differences in activities and substrate specificity of human and murine pyrimidine nucleoside phosphorylases: implications for chemotherapy with 5-fluoropyrimidines. el Kouni MH; el Kouni MM; Naguib FN Cancer Res; 1993 Aug; 53(16):3687-93. PubMed ID: 8339277 [TBL] [Abstract][Full Text] [Related]
4. Development of inhibitors of pyrimidine metabolism. Cha SM Yonsei Med J; 1989 Dec; 30(4):315-26. PubMed ID: 2697111 [TBL] [Abstract][Full Text] [Related]
5. Pyrimidine acyclonucleosides, inhibitors of uridine phosphorylase. Niedzwicki JG; el Kouni MH; Chu SH; Cha S Biochem Pharmacol; 1981 Aug; 30(15):2097-101. PubMed ID: 7295329 [No Abstract] [Full Text] [Related]
6. Structure-activity relationship of nucleobase ligands of uridine phosphorylase from Toxoplasma gondii. Iltzsch MH; Klenk EE Biochem Pharmacol; 1993 Nov; 46(10):1849-58. PubMed ID: 8250971 [TBL] [Abstract][Full Text] [Related]
7. Inhibition of uridine phosphorylase by pyrimidine nucleoside analogs and consideration of substrate binding to the enzyme based on solution conformation as seen by NMR spectroscopy. Veres Z; Neszmélyi A; Szabolcs A; Dénes G Eur J Biochem; 1988 Dec; 178(1):173-81. PubMed ID: 3203686 [TBL] [Abstract][Full Text] [Related]
8. 5-benzylacyclouridine and 5-benzyloxybenzylacyclouridine, potent inhibitors of uridine phosphorylase. Niedzwicki JG; Chu SH; el Kouni MH; Rowe EC; Cha S Biochem Pharmacol; 1982 May; 31(10):1857-61. PubMed ID: 7104017 [TBL] [Abstract][Full Text] [Related]
9. Inhibition of uridine phosphorylase from Giardia lamblia by pyrimidine analogs. Jiménez BM; Kranz P; Lee CS; Gero AM; O'Sullivan WJ Biochem Pharmacol; 1989 Nov; 38(21):3785-9. PubMed ID: 2597172 [TBL] [Abstract][Full Text] [Related]
10. Inhibition of uridine phosphorylase by some pyrimidine derivatives. Grancharov K; Mladenova J; Golovinsky E Biochem Pharmacol; 1991 Jun; 41(11):1769-72. PubMed ID: 2043165 [No Abstract] [Full Text] [Related]
11. Structure-activity relationship of pyrimidine base analogs as ligands of orotate phosphoribosyltransferase. Niedzwicki JG; Iltzsch MH; el Kouni MH; Cha S Biochem Pharmacol; 1984 Aug; 33(15):2383-95. PubMed ID: 6466360 [TBL] [Abstract][Full Text] [Related]
12. Inhibition of uridine phosphorylase from Escherichia coli by benzylacyclouridines. Park KS; el Kouni MH; Krenitsky TA; Chu SH; Cha S Biochem Pharmacol; 1986 Nov; 35(21):3853-5. PubMed ID: 3535805 [TBL] [Abstract][Full Text] [Related]
13. Specificity of pyrimidine nucleoside phosphorylases and the phosphorolysis of 5-fluoro-2'-deoxyuridine. Woodman PW; Sarrif AM; Heidelberger C Cancer Res; 1980 Mar; 40(3):507-11. PubMed ID: 6451286 [TBL] [Abstract][Full Text] [Related]
14. Activity and substrate specificity of pyrimidine phosphorylases and their role in fluoropyrimidine sensitivity in colon cancer cell lines. Temmink OH; de Bruin M; Turksma AW; Cricca S; Laan AC; Peters GJ Int J Biochem Cell Biol; 2007; 39(3):565-75. PubMed ID: 17098463 [TBL] [Abstract][Full Text] [Related]
15. Inhibitor properties of some 5-substituted uracil acyclonucleosides, and 2,2'-anhydrouridines versus uridine phosphorylase from E. coli and mammalian sources. Drabikowska AK; Lissowska L; Veres Z; Shugar D Biochem Pharmacol; 1987 Dec; 36(23):4125-8. PubMed ID: 3318842 [TBL] [Abstract][Full Text] [Related]
16. Phenylselenenyl- and phenylthio-substituted pyrimidines as inhibitors of dihydrouracil dehydrogenase and uridine phosphorylase. Goudgaon NM; Naguib FN; el Kouni MH; Schinazi RF J Med Chem; 1993 Dec; 36(26):4250-4. PubMed ID: 8277507 [TBL] [Abstract][Full Text] [Related]
17. Effects of modifications in the pentose moiety and conformational changes on the binding of nucleoside ligands to uridine phosphorylase from Toxoplasma gondii. el Kouni MH; Naguib FN; Panzica RP; Otter BA; Chu SH; Gosselin G; Chu CK; Schinazi RF; Shealy YF; Goudgaon N; Ozerov AA; Ueda T; Iltzsch MH Biochem Pharmacol; 1996 Jun; 51(12):1687-700. PubMed ID: 8687484 [TBL] [Abstract][Full Text] [Related]
18. Metabolism of pyrimidine bases and nucleosides by pyrimidine-nucleoside phosphorylases in cultured human lymphoid cells. Pérignon JL; Bories DM; Houllier AM; Thuillier L; Cartier PH Biochim Biophys Acta; 1987 Apr; 928(2):130-6. PubMed ID: 3567226 [TBL] [Abstract][Full Text] [Related]
19. Synthesis and evaluation of 6-methylene-bridged uracil derivatives. Part 2: optimization of inhibitors of human thymidine phosphorylase and their selectivity with uridine phosphorylase. Yano S; Kazuno H; Sato T; Suzuki N; Emura T; Wierzba K; Yamashita J; Tada Y; Yamada Y; Fukushima M; Asao T Bioorg Med Chem; 2004 Jul; 12(13):3443-50. PubMed ID: 15186830 [TBL] [Abstract][Full Text] [Related]
20. Irreversible enzyme inhibitors. 202. Candidate active-site-directed irreversible inhibitors of 5-fluoro-2'-deoxyuridine phosphorylase from Walker 256 rat tumor derived from 1-benzyl-5-(3-ethoxybenzyl)uracil. Kelley JL; Baker BR J Med Chem; 1982 May; 25(5):600-3. PubMed ID: 6211547 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]